From: | Becker's ASC Review <editorial@beckershealthcare.com> |
Subject: | Moody's: Envision could sell AmSurg for $3B-$3.5B - 6 things to know | CMS to pay separately for Exparel, nonopioid pain management at ASCs in 2018 | 21 latest hospital, health system exec moves | 3Qs with Seaside Surgery Center's Cindy Schuetz on ASC success |
Preheader: | |
Reply: | editorial@beckershealthcare.com |
|